Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

tet_pLKO.1_puro_shNRF2 #2 Citations (3)

Originally described in: Sporadic activation of an oxidative stress-dependent NRF2-p53 signaling network in breast epithelial spheroids and premalignancies.
Pereira EJ, Burns JS, Lee CY, Marohl T, Calderon D, Wang L, Atkins KA, Wang CC, Janes KA Sci Signal. 2020 Apr 14;13(627). pii: 13/627/eaba4200. doi: 10.1126/scisignal.aba4200.
PubMed Journal

Articles Citing tet_pLKO.1_puro_shNRF2 #2

Articles
The Knockdown of Nrf2 Suppressed Tumor Growth and Increased the Sensitivity to Lenvatinib in Anaplastic Thyroid Cancer. Gong Z, Xue L, Wei M, Liu Z, Vlantis AC, van Hasselt CA, Chan JYK, Li D, Zeng X, Tong MCF, Chen GG. Oxid Med Cell Longev. 2021 Sep 4;2021:3900330. doi: 10.1155/2021/3900330. eCollection 2021. PubMed
Microbial Metabolites Orchestrate a Distinct Multi-Tiered Regulatory Network in the Intestinal Epithelium That Directs P-Glycoprotein Expression. Foley SE, Dente MJ, Lei X, Sallis BF, Loew EB, Meza-Segura M, Fitzgerald KA, McCormick BA. mBio. 2022 Aug 30;13(4):e0199322. doi: 10.1128/mbio.01993-22. Epub 2022 Aug 15. PubMed
Harnessing the Noncanonical Keap1-Nrf2 Pathway for Human Cytomegalovirus Control. Ghosh AK, Su YP, Forman M, Keyes RF, Smith BC, Hu X, Ferrer M, Arav-Boger R. J Virol. 2023 Apr 27;97(4):e0016023. doi: 10.1128/jvi.00160-23. Epub 2023 Mar 20. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.